DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Celivarone
Celivarone
Cardiac Drug Therapy
Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix
Efficacy of Amiodarone in the Treatment of Ventricular
Synopsis Style Clinical Study Report 18-Nov-2011 SSR149744 - DRI10936 - Celivarone Version Number: 1 (Electronic 1.0)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WHO Drug Information Vol. 20, No. 3, 2006
WTO Documents Online
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Sanofi-Aventis' Multaq Fails to Shine Following Mixed Data
WO 2010/059119 Al
Tilburg University Towards a Comprehensive Understanding Of
SSR149744C (Celivarone)
M. Gabriel Khan Cardiac Drug Therapy 8Th Edition CONTEMPORARY CARDIOLOGY
Jy Le Heuzey
Annual Report on Form 20-F 2009
Who Drug Information
Atrial Fibrillation
Combined Na+/Ca2+ Exchanger and L-Type Calcium Channel Block As a Potential Strategy to Suppress Arrhythmias and Maintain Ventricular Function
Top View
Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia
Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS
Recent Advances in Pharmacotherapy of Atrial Fibrillation J
Drug Therapy for Atrial Fibrillation
(19) United States (12) Patent Application Publication (10) Pub
Com(2010)0397
Advances in the Management of Atrial Fibrillation
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
En European Union
SANOFI SSR149744/Celivarone
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Synopsis 28-Nov-2007 DRI5349 2.0 Approved